By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Kuros Biosurgery AG 

Technoparkstrasse 1

Zurich    CH-8005  Switzerland
Phone: 41-0-44-445-36-00 Fax: 41-0-44-445-36-01


SEARCH JOBS


Industry
Biotechnology






Company News
Kuros Biosurgery AG Completes Patient Recruitment in a Phase IIb Clinical Trial With KUR-211 for Diabetic Foot Ulcers 9/1/2011 7:18:56 AM
Kuros Biosurgery AG Completes Patient Recruitment in its European Clinical Study With KUR-023, its Novel Dural Sealant Product Candidate 8/17/2011 5:55:23 AM
Kuros Biosurgery AG Announces Allowance of US Patent for the Local Application of Parathyroid Hormone (PTH) for Bone Healing 7/19/2011 6:23:26 AM
Kuros Biosurgery AG Announces Allowance of European Patent for Synthetic Biomaterials 6/20/2011 6:45:31 AM
Kuros Biosurgery AG Completes Patient Recruitment In A Phase Iib Trial Of Kur-111 In Patients With Tibial Plateau Fractures 6/8/2009 2:05:45 PM
Kuros Biosurgery AG Announces Grant Of United States Patent For Synthetic Biomaterials 10/13/2008 2:17:03 PM
Kuros Biosurgery AG and Aeris Therapeutics, Inc. Announce Exclusive License Agreement in the Field of Lung Volume Reduction 9/23/2008 6:48:19 AM
Kuros Biosurgery AG Announces Results Of ONE-Month Follow-Up Of Phase IIa Trial of KUR-212 in Patients with Burns requiring Mesh Grafting; KUR-212 Meets Phase IIa Trial Primary Endpoint 8/11/2008 11:51:36 AM
Kuros Biosurgery AG Appoints Beat Neukom as its Chief Financial Officer 7/7/2008 12:36:10 PM
Kuros Biosurgery AG Starts Phase IIb Clinical Trial With Kur-113 In Open Tibial Fractures 6/10/2008 9:28:39 AM
12
//-->